Design, Synthesis, biological investigations and molecular interactions of triazole linked tacrine glycoconjugates as Acetylcholinesterase inhibitors with reduced hepatotoxicity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, Synthesis, biological investigations and molecular interactions of triazole linked tacrine glycoconjugates as Acetylcholinesterase inhibitors with reduced hepatotoxicity
Authors
Keywords
Glyco-conjugates, Enzyme Kinetics, Hepatotoxicity, Molecular docking, Molecular dynamics
Journal
BIOORGANIC CHEMISTRY
Volume 118, Issue -, Pages 105479
Publisher
Elsevier BV
Online
2021-11-14
DOI
10.1016/j.bioorg.2021.105479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In the Search of Glycoside-Based Molecules as Antidiabetic Agents
- (2019) Aleksandra Pałasz et al. Topics in Current Chemistry
- Development of tacrine-bifendate conjugates with improved cholinesterase inhibitory and pro-cognitive efficacy and reduced hepatotoxicity
- (2018) Juan Cen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors
- (2018) Gaochan Wu et al. MedChemComm
- Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors
- (2018) Zbigniew Dutkiewicz et al. BIOINORGANIC CHEMISTRY AND APPLICATIONS
- A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease
- (2017) Bilqees Sameem et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Neuroinflammation in Alzheimer's Disease: Mechanisms, Pathologic Consequences, and Potential for Therapeutic Manipulation
- (2017) Kenneth Hensley JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer's Disease and the Amyloid-β Peptide
- (2017) M. Paul Murphy et al. JOURNAL OF ALZHEIMERS DISEASE
- Synthesis, Characterization, and Biological Evaluation of Some Novel Glycosyl 1,3,4-Thiadiazole Derivatives as Acetylcholinesterase Inhibitors
- (2015) Wei-wei Liu et al. HETEROCYCLES
- Tacrine–propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer’s disease
- (2015) Fei Mao et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Tacrine–Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity
- (2015) Eugenie Nepovimova et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multifunctional Tacrine Derivatives in Alzheimer’s Disease
- (2014) Anna Minarini et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Lost after translation: missorting of Tau protein and consequences for Alzheimer disease
- (2014) Hans Zempel et al. TRENDS IN NEUROSCIENCES
- Oxidative stress in Alzheimer’s disease
- (2014) Zhichun Chen et al. Neuroscience Bulletin
- Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer’s disease
- (2013) Alejandro Romero et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity
- (2013) Fei Mao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis of glucose-tagged triazolium ionic liquids and their application as solvent and ligand for copper(I) catalyzed amination
- (2013) Abadh Kishor Jha et al. TETRAHEDRON LETTERS
- Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
- (2013) Benjamin Lam et al. Alzheimers Research & Therapy
- Possible Role of Hydroxylated Metabolites of Tacrine in Drug Toxicity and Therapy of Alzheimers Disease
- (2008) Jiri Patocka et al. CURRENT DRUG METABOLISM
- Prevalence of dementia after age 90: Results from The 90+ Study
- (2008) M. M. Corrada et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started